Skip to main content

Table 1 Patients’ characteristics

From: Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients

Characteristics

Survivors

Non-survivors

p value

Number of patients

68

33

 

Age (years)

53.0 ± 2.4 (18–85)

70.5 ± 3.5 (28–90)

0.000*

Male, gender (%)

38 (55.9%)

19 (57.6%)

0.872

Burn degree (2nd/2nd and 3rd/3rd)

8/50/10

1/24/8

0.219

ABSI score

8.0 ± 0.2 (4–13)

10.4 ± 0.4 (8–17)

0.000*

TBSA burned (%)

28.2 ± 1.6 (14–75)

40.7 ± 3.6 (15–90)

0.000*

Inhalation injury (%)

45 (66.2%)

15 (45.5%)

0.047*

Mechanical ventilation (%)

36 (52.9%)

4 (12.1%)

0.000*

Days of mechanical ventilation

11.3 ± 2.3 (0–70)

22.4 ± 3.8 (0–76)

0.000*

Duration of sepsis episode (days)

5.5 ± 0.6 (1–24)

10.6 ± 1.8 (1–43)

0.005*

Antimicrobial therapy (days)

20.8 ± 2.4 (0–104)

18.5 ± 3.4 (0–64)

0.374

Number of surgical interventions

4.3 ± 0.3 (0–15)

2.5 ± 0.6 (0–12)

0.000*

Length of stay (days)

43.1 ± 3.2 (8–180)

29.9 ± 5.0 (3–113)

0.001*

  1. Values are mean ± S.E. (min-max)
  2. *Significant difference at p value < 0.05
  3. ABSI Abbreviated Burn Severity Index, TBSA Total body surface area, S.E. Standard error